Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,427 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06184542RecruitingPhase 1
New DTaP vaccine safety trial for children
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
Dazhou, SichuanAges 2 months–6 years - NCT06197139RecruitingPhase 1
Study of a new targeted radiation therapy for advanced solid tumors
This trial tests an investigational drug called [177Lu]Lu-XT117, which delivers a small dose of radiation directly to cancer cells that have a specific protein called FAP. It is for people with advanced solid tumors who have run out of standard treatment options or cannot tolerate them.
GuangzhouAges 18 years+ - NCT06190639RecruitingPhase 2
Sintilimab after surgery for node-positive esophageal cancer
This trial tests whether giving the immunotherapy drug Sintilimab after surgery can help prevent esophageal cancer from coming back. It is for people whose cancer had spread to lymph nodes and who have already had their tumor removed.
Hangzhou, ZhejiangAges 18 years+ - NCT06187311RecruitingPhase 4
Rivaroxaban for atrial fibrillation patients
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
SeoulAges 19–99 - NCT05603520Recruiting
Study of how the aorta varies in healthy people and patients
This study uses MRI scans to understand how different parts of the aorta look and behave, including in healthy volunteers and people with aortic problems. It may help researchers better describe differences in the aorta that could improve future diagnosis or treatment planning.
DüsseldorfAges 18 years+ - NCT07871708Recruiting
Beauty device for skin concerns
This study tests a handheld beauty device that may improve wrinkles, skin firmness, and skin texture. If you have signs of aging or skin texture issues, you might be eligible to try it at no cost.
Baltimore, MarylandAges 30–65 - NCT06205576Recruiting
Balloon treatment for narrowed AV fistula veins
This trial tests a balloon device to open up narrowed veins in an AV fistula used for dialysis. It may help if your fistula has a blockage that causes problems like high pressure or low blood flow.
BeijingAges 18–85 - NCT07865793RecruitingPhase 2
Lattice radiation with immunotherapy for advanced tumors
This trial tests a new way to give radiation called lattice therapy together with immunotherapy drugs that help your immune system fight cancer. It is for people with advanced solid tumors that have grown or spread, with at least one large tumor that can be measured.
Shenzhen, GuangdongAges 18–70 - NCT07860216RecruitingPhase 3
RSV vaccine safety and immune response study for older adults
This trial tests an experimental vaccine to protect older adults against respiratory syncytial virus (RSV), a common virus that can cause serious lung infections. It looks at whether the vaccine is safe and how well it boosts immunity. If you are healthy and over 60, you might be able to join.
GuiZhou, GuizhouAges 60 years+ - NCT07855679Recruiting
Pulmonary embolism tracking from emergency care to long-term follow-up
This study follows people who have had a pulmonary embolism (a blood clot in the lungs) to understand their health over time and improve future care. It does not test a new treatment but collects information to learn more about recovery.
Bagno a Ripoli, TuscanyAges 18 years+ - NCT07872826Enrolling by invitationPhase 3
Study of pain relief injection after hip replacement surgery
This study tests a new pain-relief injection given during hip replacement surgery to reduce pain after the operation. The goal is to help patients recover with less discomfort and possibly reduce the need for other pain medications.
ChangshaAges 18–80 - NCT06211647RecruitingPhase 1
177Lu XT117 for advanced solid tumors
This trial tests a new radioactive drug, [177Lu]Lu-XT117, that seeks out and delivers radiation to solid tumors that have a specific marker called FAP. It's for people whose cancer has not responded to other treatments or who have no other options.
BeijingAges 18 years+ - NCT06215950RecruitingPhase 1
CAR-T cell therapy for advanced gynecologic cancer with CD70 protein
This trial tests a new treatment called CAR-T cells that target a protein called CD70 found on some gynecologic cancer cells. It is for people whose cancer has advanced or spread and has not responded to or stopped responding to standard treatments.
Wuhu, AnhuiAges 18 years+ - NCT06033014Recruiting
New decision support tool for heart disease patients
This trial tests a new decision support tool for people with ischemic heart disease (reduced blood flow to the heart). It aims to help doctors and patients make better treatment decisions. You may be able to join if you are hospitalized for various forms of heart disease and have significant blockages found during a heart catheterization.
Copenhagen ØAges 18 years+ - NCT06142669Recruiting
Knee revision study using EVOLUTION parts
This study checks how well a specific knee replacement system works in people who need a revision knee surgery (replacing a previous implant). If you have had or will have this surgery with the EVOLUTION parts, researchers will follow you for 10 years to see how the implant performs.
Milan, Piazza C. Ferrari 1 20122 MilanAges 21 years+ - NCT06234137Recruiting
Chemo plus targeted therapy for advanced HER2+ breast cancer
This trial tests a combination of chemotherapy (docetaxel and carboplatin) plus two targeted drugs (Inetetamab and Pyrotinib) for people with locally advanced HER2-positive breast cancer that has not spread to other parts of the body. The goal is to see if this powerful combo can shrink the tumor before surgery or other treatments.
Wenzhou, ZhejiangAges 18–75 - NCT06221709Recruiting
Radiofrequency for hip arthritis pain: a clinical trial
This trial tests whether a treatment called continuous radiofrequency can reduce pain from hip arthritis. It is for people with moderate arthritis in one hip who have had pain for more than six months.
Brasília, Federal DistrictAges 18 years+ - NCT04688593Recruiting
Follow-up study of a hip implant cup and stem system
This study looks at how well a specific hip implant (the acetabular cup and femoral stem) works over short, mid, and long-term follow-up. It may help you and other patients by improving understanding of implant outcomes after surgery.
KielAges 18 years+ - NCT06226857RecruitingPhase 3
Anti-EGFR for left-sided, RAS wild-type metastatic colorectal cancer
This trial tests whether anti-EGFR therapy works better for people with left-sided colorectal cancer that has spread, whose tumors do not have certain gene mutations (RAS wild-type). It is for those who have not yet had treatment for metastatic disease.
MoscowAges 18–99 - NCT07869238Recruiting
Safety study of NMS-01 for mild to moderate Alzheimer's disease
This trial tests a new treatment called NMS-01 for people with mild to moderate Alzheimer's disease. It aims to see if it's safe and may help with symptoms.
Seoul, SeodaemunAges 50–85 - NCT07864428Enrolling by invitation
Virtual reality relaxation for nursing students
This trial tests whether using virtual reality to relax before a clinical exam helps reduce anxiety. It may help nursing students feel calmer and perform better.
Ankara, AAAges 18 years+ - NCT07856225Recruiting
Breast cancer outcomes by tumor type
This study looks at how different types of breast cancer respond to treatment. It reviews medical records of patients treated at a specific hospital to understand outcomes better.
Bogotá, Bogota D.C.Ages 18 years+ - NCT06231953Recruiting
Building a multi-cancer early detection test using DNA
This study uses a blood test to look for DNA changes that could signal cancer early. It includes both people with cancer and healthy volunteers to help build a better screening tool.
SeoulAges 19 years+ - NCT05971537RecruitingPhase 4
Antibiotic lock treatment for repeat peritonitis in catheter patients
This trial studies using an “antibiotic lock” inside a Tenckhoff catheter to prevent relapsing or repeat peritonitis in people on peritoneal dialysis. It may help stop infections that come back soon after antibiotics, especially when the same germ is causing them.
Tai PoAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,427 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.